Torsion dystonias and other involuntary movements (Formulary)

TAM (Treatments and Medicines) NHS Highland

What's new / Latest updates

02/06/23 - Botulinum Toxin Type B solution for injection vial 2500units/0·5mL, 5000 units/1mL, 10 000units/2mL (NeuroBloc®) (s) removed (discontinued)

MHRA advice: Botulinum toxin products: rare but serious risks (December 2014) (www.gov.uk).

BOTULINUM TOXIN TYPE A - (First line)

Important: Therapy notes

Also used under specialist advice for migraine (Analgesics)
bladder dysfunction and urinary incontinence
spasticity (Drugs used in neuromuscular disorders)
blepharospasm (Tear deficiency, ocular lubricants and astringents)
off-label indication for Raynaud’s phenomenon.

Important: Formulation and dosage details

Formulation:

Powder for solution for injection vial 50 units, 100 units (Xeomin^®) (s)

Important: Formulation and dosage details

Formulation:

Powder for solution for injection vial 50 units, 100 units (Botox^®) (s)

Important: Formulation and dosage details

Formulation:

Powder for solution for injection vial 300 units, 500 units (Dysport^®) (s)

Torsion dystonias and other involuntary movements (Formulary)

BOTULINUM TOXIN TYPE A - (First line)

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Important: Formulation and dosage details

Formulation:

Important: Formulation and dosage details

Formulation:

Editorial Information